CNE000000H87
CNE000000H87
TONGHUA DONGBAO MEDICINES CO LT
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 15.43B EUR | 15.75B EUR | 18.59B EUR | 16B EUR |
Enterprise Value | 13.69B EUR | 15.11B EUR | 17.53B EUR | 15.09B EUR |
Valuation Multiples | ||||
Trailing P/E | 11.94x | 50.39x | 73.69x | 68.21x |
Forward P/E | 21.89x | -- | -- | -- |
Price to Sales | 4.97x | 6.79x | 8.31x | 7.47x |
Price to Book | 2.11x | 2.3x | 2.57x | 2.25x |
EV/Revenue | 4.41x | 6.51x | 7.83x | 7.05x |
EV/EBITDA | 14.17x | 28.87x | 36.05x | 34.82x |
Price to FCF (P/FCF) | -- | 37.06x | 45.3x | 61.73x |
EV/FCF | -- | 35.57x | 42.72x | 58.22x |
FCF Yield | -1.69% | 2.7% | 2.21% | 1.62% |